Clinical BioManufacturing Facility

The Clinical BioManufacturing Facility is the University of Oxford's GMP-licensed manufacturing facility, producing biological investigational medicinal products for early-phase clinical trials.

The facility holds an MHRA Manufacturer's Authorisation for Investigational Medicinal Products and manufactures viral vector vaccines and advanced therapy medicinal products including gene and cell therapy products.

It serves as a bridge between academic research and clinical drug development, supporting both university and commercial collaborators in progressing novel biologics into Phase I/II trials.